Free Trial
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Price, News & Analysis

Mesa Laboratories logo
$91.82 -1.12 (-1.21%)
As of 01:21 PM Eastern

About Mesa Laboratories Stock (NASDAQ:MLAB)

Key Stats

Today's Range
$91.82
$95.29
50-Day Range
$92.73
$128.00
52-Week Range
$87.80
$155.12
Volume
78,857 shs
Average Volume
54,849 shs
Market Capitalization
$501.34 million
P/E Ratio
N/A
Dividend Yield
0.70%
Price Target
$130.00
Consensus Rating
Hold

Company Overview

Mesa Laboratories Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
62nd Percentile Overall Score

MLAB MarketRank™: 

Mesa Laboratories scored higher than 62% of companies evaluated by MarketBeat, and ranked 379th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Mesa Laboratories has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 1 buy rating, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Mesa Laboratories has only been the subject of 1 research reports in the past 90 days.

  • Read more about Mesa Laboratories' stock forecast and price target.
  • Earnings Growth

    Earnings for Mesa Laboratories are expected to grow by 9.00% in the coming year, from $8.00 to $8.72 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Mesa Laboratories is -248.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Mesa Laboratories is -248.16, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Mesa Laboratories has a P/B Ratio of 3.12. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Mesa Laboratories' valuation and earnings.
  • Percentage of Shares Shorted

    3.54% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 0.66%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Mesa Laboratories has a dividend yield of 0.62%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Mesa Laboratories does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Mesa Laboratories will have a dividend payout ratio of 7.34% next year. This indicates that Mesa Laboratories will be able to sustain or increase its dividend.

  • Read more about Mesa Laboratories' dividend.
  • Percentage of Shares Shorted

    3.54% of the float of Mesa Laboratories has been sold short.
  • Short Interest Ratio / Days to Cover

    Mesa Laboratories has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Mesa Laboratories has recently increased by 0.66%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Mesa Laboratories has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 7 news articles for Mesa Laboratories this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Mesa Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $296,507.00 in company stock.

  • Percentage Held by Insiders

    Only 4.40% of the stock of Mesa Laboratories is held by insiders.

  • Percentage Held by Institutions

    90.60% of the stock of Mesa Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Mesa Laboratories' insider trading history.
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

MLAB Stock News Headlines

Mesa Laboratories declares $0.16 dividend
"I'm risking my reputation on this"
Behind closed doors, away from the mainstream media's eyes, the smartest minds in crypto are all seeing the same signals. They're positioning themselves for something unprecedented. And after 17 million podcast downloads and over 600 insider interviews, I finally connected all the dots… What I discovered was so explosive, so potentially life-changing, that I had to put it all in a book.
MESA LABS DECLARES QUARTERLY DIVIDEND
See More Headlines

MLAB Stock Analysis - Frequently Asked Questions

Mesa Laboratories' stock was trading at $131.87 at the beginning of 2025. Since then, MLAB shares have decreased by 30.4% and is now trading at $91.82.

Mesa Laboratories, Inc. (NASDAQ:MLAB) issued its quarterly earnings results on Tuesday, February, 4th. The medical instruments supplier reported $2.07 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.41 by $0.66. Mesa Laboratories had a negative net margin of 0.82% and a positive trailing twelve-month return on equity of 27.51%.

Top institutional shareholders of Mesa Laboratories include Kings Path Partners LLC (0.06%). Insiders that own company stock include John Bradley Schmieder, Gary M Owens, Evan Guillemin, John Sakys, Shannon Hall and Brian David Archbold.
View institutional ownership trends
.

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mesa Laboratories investors own include American Water Works (AWK), Waste Connections (WCN), AU Optronics (AUOTY), DiamondRock Hospitality (DRH), The RMR Group (RMR), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM).

Company Calendar

Last Earnings
2/04/2025
Record date for 6/16 Dividend
5/30/2025
Ex-Dividend for 6/16 Dividend
5/30/2025
Dividend Payable
6/16/2025
Today
7/08/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:MLAB
Employees
680
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$130.00
High Stock Price Target
$160.00
Low Stock Price Target
$100.00
Potential Upside/Downside
+39.9%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
11.62
P/E Growth
N/A
Net Income
-$1.97 million
Pretax Margin
2.47%

Debt

Sales & Book Value

Annual Sales
$240.98 million
Cash Flow
$11.02 per share
Price / Cash Flow
8.43
Book Value
$29.42 per share
Price / Book
3.16

Miscellaneous

Free Float
5,215,000
Market Cap
$507.45 million
Optionable
Not Optionable
Beta
0.86

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:MLAB) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners